Aziz, N. A., Claassen, D., Petersén, Å., & Weydt, P. (2026). β-Blocker effects in huntington's disease: A caution on clinical interpretation. Journal of Huntington's Disease, 15(1), 179. https://doi.org/10.1177/18796397251401745
Chicago Style (17th ed.) CitationAziz, N Ahmad, Daniel Claassen, Åsa Petersén, and Patrick Weydt. "β-Blocker Effects in Huntington's Disease: A Caution on Clinical Interpretation." Journal of Huntington's Disease 15, no. 1 (2026): 179. https://doi.org/10.1177/18796397251401745.
MLA (9th ed.) CitationAziz, N Ahmad, et al. "β-Blocker Effects in Huntington's Disease: A Caution on Clinical Interpretation." Journal of Huntington's Disease, vol. 15, no. 1, 2026, p. 179, https://doi.org/10.1177/18796397251401745.
Warning: These citations may not always be 100% accurate.